Zymeworks Total Assets 2016-2022 | ZYME
Zymeworks total assets from 2016 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Zymeworks Annual Total Assets
(Millions of US $) |
| 2021 |
$389 |
| 2020 |
$538 |
| 2019 |
$368 |
| 2018 |
$244 |
| 2017 |
$132 |
| 2016 |
$94 |
| 2015 |
$23 |
Zymeworks Quarterly Total Assets
(Millions of US $) |
| 2022-06-30 |
$369 |
| 2022-03-31 |
$430 |
| 2021-12-31 |
$389 |
| 2021-09-30 |
$420 |
| 2021-06-30 |
$472 |
| 2021-03-31 |
$490 |
| 2020-12-31 |
$538 |
| 2020-09-30 |
$572 |
| 2020-06-30 |
$607 |
| 2020-03-31 |
$637 |
| 2019-12-31 |
$368 |
| 2019-09-30 |
$400 |
| 2019-06-30 |
$415 |
| 2019-03-31 |
$238 |
| 2018-12-31 |
$244 |
| 2018-09-30 |
$194 |
| 2018-06-30 |
$211 |
| 2018-03-31 |
$114 |
| 2017-12-31 |
$132 |
| 2017-09-30 |
$100 |
| 2017-06-30 |
$115 |
| 2017-03-31 |
$80 |
| 2016-12-31 |
$94 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$23 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.561B |
$0.412B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
